Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |